New cancer drug QXL138AM enters first human tests
Disease control
Recruiting now
This early-stage study tests a new drug, QXL138AM, for safety in about 100 people with advanced solid tumors (like ovarian, pancreatic, lung, or breast cancer) or multiple myeloma. Participants must have tried other treatments without success. The study will find the right dose a…
Phase: PHASE1 • Sponsor: Nammi Therapeutics Inc • Aim: Disease control
Last updated May 04, 2026 16:24 UTC